David Schwartz

Partner at Smart & Biggar

David Schwartz is a respected IP leader who brings over 25 years of experience in patent law in the fields of biotechnology, pharmaceuticals, chemistry and plant breeders’ rights. Mr Schwartz advises on regulatory matters relating to the Patented Medicines (Notice of Compliance) Regulations, data protection under the Food and Drug Regulations, and matters concerning the Patented Medicine Prices Review Board. He appears regularly in oral proceedings before the Patent Appeal Board and has handled first-to-invent conflicts under the pre-1989 Patent Act.

Mr Schwartz is a well-known thought leader in the IP industry and has testified on patent law reform before both the House of Commons Standing Committee on Industry, Science and Technology and the Senate National Finance Committee. He has lectured on patent law at Queen’s University and the University of Ottawa, and he was thrice named Ottawa’s “Lawyer of the Year” in Biotechnology Law by The Best Lawyers in Canada. He has also been recognised by Expert Guides: Life Sciences, LMG Life Sciences, The Canadian Legal LEXPERT Directory, MIP’s IP Stars Handbook: Patents and Who’s Who Legal: Canada.

Mr Schwartz is a past president of the Intellectual Property Institute of Canada and former chair of the Biotechnology Committee. He is a member of the American Intellectual Property Law Association and International Association for the Protection of Intellectual Property, and he is a registered patent and trademark agent.

Firm details

Smart & Biggar
55 Metcalfe Street
Suite 900
Ottawa ON K1P 5Y6
Canada

Contact details

See firm profile